Beheshteh Sohrabi

Dr. Beheshteh Sohrabi


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2008 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
BSBeheshteh Sohrabi
Beheshteh Sohrabi
HGHussein Gharibi
Hussein Gharibi
BTBehnoosh Tajik
Behnoosh Tajik
SJSoheila Javadian
Soheila Javadian
MHMajid Hashemianzadeh
Majid Hashemianzadeh

28 April 2021 in Open Biology
Verified
Journal Article
Open access
FAFatemeh Aliabadi
Fatemeh Aliabadi
BSBeheshteh Sohrabi
Beheshteh Sohrabi
Ebrahim MostafaviEbrahim Mostafavi
Ebrahim Mostafavi
Hamidreza Pazoki ToroudiHamidreza Pazoki Toroudi
Hamidreza Pazoki Toroudi
TWThomas J. Webster
Thomas J. Webster
Despite all the other cells that have the potential to prevent cancer development and metastasis through tumour suppressor proteins, cancer cells can upregulate the ubiquitin–proteasome system (UPS) by which they can degrade tumour suppressor proteins and avoid apoptosis. This system plays an extensive role in cell regulation organized in two steps. Each step has an important role in controlling cancer. This demonstrates the importance of understanding UPS inhibitors and improving these inhibitors to foster a new hope in cancer therapy. UPS inhibitors, as less invasive chemotherapy drugs, are increasingly used to alleviate symptoms of various cancers in malignant states. Despite their success in reducing the development of cancer with the lowest side effects, thus far, an appropriate inhibitor that can effectively inactivate this system with the least drug resistance has not yet been fully investigated. A fundamental understanding of the system is necessary to fully elucidate its role in causing/controlling cancer. In this review, we first comprehensively investigate this system, and then each step containing ubiquitination and protein degradation as well as their inhibitors are discussed. Ultimately, its advantages and disadvantages and some perspectives for improving the efficiency of these inhibitors are discussed.

4 June 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
KCKarim Khanmohammadi Chenab
Karim Khanmohammadi Chenab
BSBeheshteh Sohrabi
Beheshteh Sohrabi
ARAtyeh Rahmanzadeh
Atyeh Rahmanzadeh
The biological and biomedical applications of superhydrophobic surface.

10 March 2014 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
BSBeheshteh Sohrabi
Beheshteh Sohrabi
NPN. Poorgholami-Bejarpasi
N. Poorgholami-Bejarpasi
NNN. Nayeri
N. Nayeri

1 January 2019 in Applied Surface Science
Verified
Journal Article
Closed access
MPMahdiyeh Poorsargol
Mahdiyeh Poorsargol
MAMahsa Alimohammadian
Mahsa Alimohammadian
BSBeheshteh Sohrabi
Beheshteh Sohrabi
MDMaryam Dehestani
Maryam Dehestani

1 February 2008 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
SJSoheila Javadian
Soheila Javadian
HGHussein Gharibi
Hussein Gharibi
ZBZahra Bromand
Zahra Bromand
BSBeheshteh Sohrabi
Beheshteh Sohrabi